Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Cancer Educ ; 39(2): 174-179, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38062342

RESUMO

The incidence of skin cancer has risen steadily over recent decades. Childhood and adolescent sun exposure remains a critical risk factor in skin cancer development, making education of high schoolers imperative for promoting sun-safe behaviors. Medical students in North Carolina recognized this need and designed a skin cancer education program focused on portraying skin cancer in individuals with all Fitzpatrick skin phototypes. Eighty-seven students completed the pre-survey, and 84 completed the post-session survey. In the post-survey, 88% of students listed actionable behavioral changes they plan to make following the presentation. Following an educational session, students were able to demonstrate their new knowledge and provide meaningful behavioral changes. This program navigated challenges posed by COVID-19 and addressed the need for more inclusive skin cancer educational material.


Assuntos
Neoplasias Cutâneas , Estudantes de Medicina , Queimadura Solar , Adolescente , Humanos , Criança , Queimadura Solar/prevenção & controle , North Carolina , Neoplasias Cutâneas/prevenção & controle , Neoplasias Cutâneas/epidemiologia , Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde
2.
Am Surg ; 90(3): 365-376, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37654225

RESUMO

INTRODUCTION: The impact of frailty on adjuvant therapies not offered to or declined by elderly breast cancer surgery patients has been understudied. METHODS: This is a retrospective review of a prospectively managed single-center database including all breast cancer patients >65 years undergoing surgery in 2021. Frailty was determined using an electronic frailty index (eFI) derived from electronic health data. Patients were categorized as Fit (eFI ≤ .10), Pre-frail (.10 < eFI ≤.21), or Frail (eFI > .21). Chart review was performed to collect data on adjuvant therapies not offered or declined. Descriptive statistics and logistic regression were performed. RESULTS: Of 133 patients, 16.5% were frail, 46.6% were pre-frail, and 36.8% were fit. Demographics were similar among groups except age and comorbidities. Of those with adjuvant therapy indicated (n = 123), 15.4% were not offered at least one indicated therapy. Of those offered therapy, some therapy was declined in 22.7%. Frail patients more often were not offered or declined some therapy (frail: 63.2%, pre-frail 36.2%, fit: 28.2%, P = .03). Frailty was associated with having some therapy not offered or declined on univariate modeling (OR 4.4 95% CI 1.4-13.5, P = .01) but not on multivariate. Being frail was associated with higher odds of readmission at 6 months on multivariate analysis (OR 9.5, 95% CI: 1.7-54.2. P = .01). CONCLUSION: Over half of frail patients are not offered or decline some adjuvant therapy. The impact of this requires further study. Given their higher odds of readmission, frail patients require close postoperative monitoring to prevent the interruption of adjuvant therapies.


Assuntos
Neoplasias da Mama , Fragilidade , Humanos , Idoso , Feminino , Fragilidade/complicações , Idoso Fragilizado , Neoplasias da Mama/cirurgia , Neoplasias da Mama/complicações , Avaliação Geriátrica , Estudos Retrospectivos , Fatores de Risco , Complicações Pós-Operatórias
3.
bioRxiv ; 2023 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-37904976

RESUMO

Background: There is considerable focus on developing strategies for identifying subclinical cardiac decline prior to cardiac failure. Myocardial tissue elasticity changes may precede irreversible cardiac damage, providing promise for an early biomarker for cardiac decline. Biomarker strategies are of particular interest in cardio-oncology due to cardiotoxic effects of anti-neoplastic therapies, particularly anthracycline-based chemotherapeutics. Current clinical methods for diagnosing cardiotoxicity are too coarse to identify cardiac decline early enough for meaningful therapeutic intervention, or too cumbersome for clinical implementation. Methods: Utilizing changes in myocardial elasticity as a biomarker for subclinical cardiac decline, we developed a biomechanical model-based elasticity imaging methodology (BEIM) to estimate spatial maps of left ventricle (LV) myocardial elasticity. In this study, we employ this methodology to assess changes in LV elasticity in a non-human primate model of doxorubicin-induced cardiotoxicity. Cardiac magnetic resonance imaging of five African Green monkeys was acquired at baseline prior to doxorubicin administration, 6-weeks, and 15-weeks after final doxorubicin dose and histopathological samples of the LV were taken at 15-weeks after final doxorubicin dose. Spatial elasticity maps of the mid-short axis plane of the LV were estimated at each image acquisition. Global and regional LV elasticity were calculated and changes between imaging time points was assessed. LV elasticity at baseline and final time point were compared to cardiomyocyte size and collagen volume fraction measurements calculated from histopathological staining of archived tissue bank samples and study endpoint tissue samples utilizing Pearson's correlation coefficients. Results: We identify significant changes in LV elasticity between each imaging time point both globally and regionally. We also demonstrate strong correlation between LV elasticity and cardiomyocyte size and collagen volume fraction measurements. Results indicate that LV elasticity estimates calculated using BEIM correlate with histopathological changes that occur due to doxorubicin administration, validating LV elasticity solutions and providing significant promise for use of BEIM to non-invasively elucidate cardiac injury. Conclusions: This methodology can show progressive changes in LV elasticity and has potential to be a more sensitive indicator of elasticity changes than current clinical measures of cardiotoxicity. LV elasticity may provide a valuable biomarker for cardiotoxic effects of anthracycline-based chemotherapeutics and cardiac disease detection.

4.
Vet Surg ; 52(7): 952-960, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37395131

RESUMO

OBJECTIVE: To report the incidence of metastatic calcification in cats with renal failure presenting for renal transplantation, and to determine if metastatic calcification detected prior to renal transplantation is associated with complication rates and patient survival. STUDY DESIGN: Retrospective case series. SAMPLE POPULATION: Seventy-four cats. METHODS: In imaging studies, 178 feline renal transplant recipients from 1998 to 2020 were evaluated for metastatic calcification. Demographic, clinicopathological data, intraoperative complications, postoperative complications, need for hemodialysis, and survival times were recorded. Exclusion criteria were cats lacking imaging reports and cats with gastric, renal, or tracheal/bronchial calcification alone. Univariable and multivariable analyses were performed to determine variables that were independently associated with survival. Kaplan-Meier analysis was used to generate survival plots and estimate median survival times with a 95% confidence interval (CI). RESULTS: Seventy four of 178 cats met the inclusion criteria. Fifteen of 74 (20.3%) cats had metastatic calcification prior to renal transplantation. Twelve of 74 (16.2%) cats developed calcification following transplantation, and 47 of 74 (63.5%) cats had no calcification during the study period. Median follow-up time was 472 days, with a range of 0-1825 days. Cats with pretransplant calcification had shorter median survival times (147 days) than cats without calcification (646 days) (p = .0013). Metastatic calcification pretransplant was associated with an increased risk of death by 240% (95% CI, 1.22-4.71). CONCLUSION: Metastatic calcification in renal transplant cats is a negative prognostic indicator and is associated with decreased survival times. CLINICAL SIGNIFICANCE: These findings may help guide therapeutic recommendations and owner expectations in cats undergoing renal transplantation.


Assuntos
Transplante de Rim , Gatos , Animais , Transplante de Rim/veterinária , Estudos Retrospectivos , Prognóstico , Estimativa de Kaplan-Meier , Taxa de Sobrevida
5.
J Am Anim Hosp Assoc ; 57(3): 121-127, 2021 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-33770163

RESUMO

Gorilla Glue contains methylene diphenyl diisocyanate that expands significantly and hardens once exposed to moisture. Case reports of methylene diphenyl diisocyanate glue ingestion in dogs document gastrointestinal foreign body formation and mechanical obstruction. Medical record queries from four veterinary hospitals identified 22 dogs with Gorilla Glue ingestion. Records were evaluated retrospectively to characterize clinical presentation, diagnostic findings, treatment, and patient outcome. Vomiting was the most common clinical sign (n = 11), with a median time from ingestion to presentation of 42 hr. Abnormal abdominal palpation (e.g., pain) was the most reported examination finding (n = 13). Radiographs were performed in 18/22 dogs, with Gorilla Glue expansion described as granular or mottled soft tissue with gas in the stomach. In 73% (11/15) of dogs requiring surgery, history, clinical findings, and survey abdominal radiographs sufficed to proceed with celiotomy. Surgical removal of the Gorilla Glue foreign body was performed via gastrotomy (n = 14) or gastrotomy and duodenotomy (n = 1). Endoscopic removal was performed in one dog. One dog with suspected mechanical obstruction was euthanized owing to financial constraints. Remaining cases were managed conservatively (n = 5). Short-term prognosis following appropriate fluid therapy and surgical or endoscopic removal was very good.


Assuntos
Doenças do Cão/diagnóstico , Corpos Estranhos/veterinária , Isocianatos , Estômago , Animais , Doenças do Cão/cirurgia , Cães , Feminino , Corpos Estranhos/diagnóstico , Hospitais Veterinários , Masculino , Registros/veterinária , Estados Unidos
6.
Zootaxa ; 3750: 375-82, 2013 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-25113706

RESUMO

Cliona tumula sp. nov. is described from the Florida Keys, Florida, USA. The new species is compared to representative Cliona spp. from the Caribbean and Indo-Pacific. Cliona tumula sp. nov. is a massive, mound-shaped zooxanthellate clionaid with a central, apical cluster of numerous oscula, slender tylostyles with variable heads and abundant, delicate spirasters with compound spines that can be concentrated at the ends, which in this species can appear as mushroom-like caps, with a skeleton in typical clionaid arrangement. It is distinguished from congeners by its epibenthic growth form that extends for 20-40 cm above the substratum, centrally located concentration of oscula, and calcareous fragments obtained from surrounding sediment that C. tumula sp. nov. incorporates in tracts that run through the choanosome perpendicular to the ectosome. This species can be locally abundant in the Florida Keys in patch reefs near sand flats, but may be restricted to the lower keys as it has not been observed on reefs to the east. 


Assuntos
Poríferos/classificação , Distribuição Animal , Estruturas Animais/anatomia & histologia , Animais , Ecossistema , Florida , Poríferos/anatomia & histologia , Poríferos/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA